Encube to buy anti-microbial brand Soframycin from Sanofi for Rs 125 cr

Will also acquire other legacy associated brands such as Sofradex (antibacterial cream), Sofracort (eye and ear drops), Soframycin-Tulle (cream) for India and Sri Lanka markets

Topical products manufacturer Encube Ethicals said on Friday that it has agreed to buy popular topical anti-microbial brand Soframycin along with a portfolio of other brands for the India and Sri Lanka markets from Sanofi. The deal size is estimated to be around Rs 125 crore.

Apart from Soframycin, Encube will also acquire other legacy associated brands such as Sofradex (antibacterial cream), Sofracort (antibacterial eye and ear drops), Soframycin-Tulle (antibacterial cream) for India and Sri Lanka markets.

Sanofi shares ended day’s trade on the BSE at Rs 8299.95 apiece, up 1.5 percent.

Soframycin is a legacy brand for Sanofi with a history of